Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
For full access to this article login to GEN Select now.
Downstream Bottlenecks: Are They Myth or Reality?
Throughput Isn’t Where It Should Be, and There Is Some Disagreement as to Why
- Like the story of the blind men describing an elephant, the answer to whether a downstream bioprocessing bottleneck exists is largely one of perception. “The situation is even worse than it was two years ago,” according to Uwe Gottschalk, Ph.D., vp of purification technology, a business unit of Sartorius ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.